Likewise, PD-1 expression was increased on activated B cells in patients with CLL (5.325 ± 0.4397) relative to the control group (4.305 ± 0.4317; p < 0.0001). Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.